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STRESS, COPING, AND EMOTIONAL DISTRESS OF MEDICALLY UNDERSERVED 
LUNG AND HEAD-AND-NECK CANCER PATIENTS 
 
The intent of this study was to investigate how lung cancer (LC) and head and neck cancer 
(HNC) patients who are medically underserved (i.e. uninsured, underinsured, low income) 
experience emotional distress (symptoms of depression and anxiety) after being diagnosed with 
LC or HNC. Participants were recruited from four Colorado hospitals. They completed a 
baseline survey which included measures of perceived stress, coping self-efficacy, depression 
symptoms, and anxiety symptoms. The Transactional Model of Stress and Coping (TMSC) was 
used as a theoretical guide for analyses about the relations of stress coping and emotional 
distress. When age, sex, and stage of cancer were controlled for, levels of perceived stress were 
observed to be positively associated with experience of emotional distress.  Further, coping was 
shown to be an effective moderator of the relation of perceived stress to emotional distress. The 
TMSC is a functional theoretical model for organizing the understanding of stress, coping and 
emotional distress for medically underserved LC and HNC patients. Further research should be 
conducted to assess for changes in these variables overtime, particularly if psychological 
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The intent of this study was to investigate how those who are medically underserved (i.e. 
uninsured, underinsured, low income) experience emotional distress after being diagnosed with 
cancer. Emotional distress, within this paper, refers to experiencing symptoms of depression and 
anxiety. Depressive symptoms relate to changes in mood and anxiety symptoms are associated 
with worry, so emotional distress is used as an umbrella term to describe difficult psychological 
states patients experience.  Depression and anxiety symptoms range from mild to severe 
(American Psychiatric Association, 2013). The participants in this study were recently given a 
diagnosis of lung cancer (LC) and/or head-and-neck cancer (HNC). Receiving a LC or HNC 
diagnosis is an incredibly stressful event and patients often experience emotional distress 
(Andrykowski & Kangas, 2010). One aim of the present study was to assess the impact of a 
stressful LC or HNC diagnosis on emotional distress, specifically in a medically underserved 
sample at baseline, before any intervention was used. Furthermore, research indicates that the 
level of emotional distress a patient experiences is related to the way they cope (Kvillemo & 
Bränström, 2014). Coping is defined as the way a person manages a stress (Lazarus & Folkman, 
1984). The second aim of this study was to determine if coping moderates the relation between 
stress of diagnosis and emotional distress among medically underserved patients who have 
recently received a LC and/or HNC diagnosis. 
Lung Cancer and Head-and-Neck Cancer 
 LC is the second most commonly diagnosed cancer in the United States (American 
Cancer Society, 2017). By the end of 2019, an estimated 228,150 individuals will have been 




of new lung cancer cases are diagnosed in men than in women with statistics indicating 
approximately 60.7 men out of 100,000 men are diagnosed with lung cancer compared to 47.7 
women out of 100,000 women (National Cancer Institute, 2016). Within ethnic groups, Non-
Hispanic White people, Non-Hispanic Black people and American Indian/Alaska Native are 
diagnosed with approximately the same rate (approximately 63 cases) per 100,00 people. Rates 
in Hispanic/Latino people and Asian/Pacific Islanders are approximately 33 cases per 100,000 
people. According to the American Cancer Society, there are two types of LC: small cell lung 
cancer and non-small cell lung cancer. About 80-85 percent of LC diagnoses are non-small cell 
LC. Cancer diagnoses are given based on stages ranging from I to IV with I indicating cancer 
cells are the most localized and IV indicating the cancer has metastasized to other parts of the 
body (ACS, 2017). Identifying the stage of the cancer informs prognosis and treatment. For those 
who are diagnosed with Stage I non-small cell LC, the 5-year survival rate is between 45-49 
percent. Stage II non-small cell LC patients have a 5-year survival rate between 30-31 percent. 
Those diagnosed at Stage III have a 5-14 percent 5-year survival rate. At Stage IV, the 5-year 
survival rate is only 1 percent (ACS, 2017). These statistics make LC the second most diagnosed 
of all cancers, and the most lethal.  
 Typically, once detected, LC is treated with surgery, chemotherapy, and radiation. 
Surgery can be an effective treatment for people diagnosed at an early stage of the LC. However, 
surgery is not always effective for later stages when cancer has already spread. LC surgery is 
considered a major operation and possible complications during and after surgery include: 
reaction to anesthesia, bleeding, blood clots, infection and pneumonia. Because of these possible 
complications, people who have good heart and lung health are often good fits for surgery. While 




surgery, like chemotherapy and radiation (ACS, 2017). Chemotherapy is a cancer treatment that 
involves the use of medication and drugs to kill cancer cells (ACS, 2018). Radiation is a 
treatment that uses “high-energy radiation to shrink tumors and kill cancer cells” (Lawrence, 
Haken, Giaccia, 2008).  
 If a treatment team establishes that a patient cannot tolerate surgery, radiation and 
chemotherapy are treatments that can be given alone, before or after surgery, or concurrent at 
any stage of LC. For those at the later stages of LC, targeted treatment drugs can be effective. 
Lastly, immunotherapy can be helpful in treating some kinds of non-small LC by stimulating a 
person’s immune system to effectively recognize and destroy cancer cells. Different treatment 
approaches are chosen based on stage of LC (ACS, 2017). 
 Many of these treatments have harsh side effects, which adds to the stress of LC 
diagnoses. Common side effects of surgery, radiation, and chemotherapy include: fatigue, nausea 
and vomiting, skin rash or peeling, loss of appetite, constipation, diarrhea, low white blood cell 
count leading to increased risk of infection, headache, mouth sore, hair loss, easily bruising or 
bleeding, loss of appetite and weight loss. Nausea has been described as one of the worst 
symptoms effecting the daily lives of LC patients (Schmidt et al., 2016). When radiation and 
chemo are given together, side effects tend to be worse (ACS, 2017). The intensity and severity 
of these harsh symptoms can add to the stress of a LC diagnosis.  
 Lung cancer often co-occurs with HNC. Co-occurrence is mostly due to metastasis, with 
cancer cells beginning in the head-and-neck region and spreading to the lungs (ACS, 2016). 
HNC includes cancer of the oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and 
salivary glands (National Cancer Institute, [NCI], 2017). The American Cancer Society (2019) 




to be detected in 2019 alone. Additionally, 53,000 new cases of oral cavity and pharynx cancer 
are estimated (ACS, 2017). Men receive a head-and-neck cancer diagnosis two-to-three times 
more often than women (ACS, 2017).  
 Head-and-neck cancers are diagnosed based on stages in the same way LC is diagnosed. 
However, because head-and-neck is an umbrella term, each type has varying ways of defining 
stage. Broadly, stage I and II HNC diagnoses are less severe and earlier in development than 
later stages III and IV. Like LC, HNC treatment varies based on specific diagnosis. Common 
treatments include surgery, chemotherapy, and radiation. Side effects of these treatments remain 
the same as listed previously for LC. As such, treatment of HNC can have severe symptoms 
which increase the stress of receiving an HNC diagnosis (National Cancer Institute, 2017).   
 Medically underserved LC and HNC patients are further disadvantaged in timely receipt 
of treatment because they are less likely to go to regular cancer screens (Ayanian, Weissman, 
Schneider, Ginsburg & Zaslavsky, 2000; Carrasquillo & Pati, 2004; Ioannou, Chapko & 
Dominitz, 2003). In the research, medically underserved is defined based on varying criteria 
including but not limited to income, insurance status, and SES. A lack of screening results in 
illness or disease having progressed to more developed stages for underserved patients 
(Roetzheim et al., 1999; Ayanian, Kohler, Abe & Esptein, 1993; Bradley, Given & Roberts, 
2001). Delayed visits to the doctor has implications for frequency and severity of LC and HNC 
for underserved patients. Research shows that people who are uninsured or underinsured are 
more likely to be diagnosed with an advanced stage of cancer development than those with 
private insurance (Halpern et al., 2008). As discussed, advanced stages of cancer are often 




As such, medically underserved LC and HNC patients may face higher stress with diagnosis and 
treatment because of their medical status. 
 Another example of health disparity for the medically underserved is related to the type 
of treatment they receive. As noted, the most common treatments for LC and HNC are surgery, 
chemotherapy and radiation (American Cancer Society, 2018). In 2012, Yorio et al. analyzed and 
reported differences in treatment for varying health insurance levels (Yorio, Yan, Xie & Gerber, 
2012). Their study provided evidence that people with Medicare or non-private health care were 
far less likely to have the standard treatment of surgery for non-small cell LC (NSCLC) stage I 
and II. For those diagnosed with Stage III NSCLC, the standard treatment is chemotherapy and 
radiation. In their study, participants with Medicare or non-private health care with Stage III 
were also less likely to receive standard treatment. Additionally, the researchers analyzed 
survival rates for the different insurance groups. The people in the non-private insurance 
category had a risk of death twice as likely as people with private insurance (Yorio, et al, 2012). 
These results indicate that treatment and survival outcomes vary greatly depending on insurance 
status. 
Stress 
 Cancer patients diagnosed with various forms of cancer experience high amounts of 
stress (Golden-Kreutz et al, 2005; Edgar, Rosberger & Nowlis, 1992). Stress is operationally 
defined in this study to mean “a relationship between the person and the environment that is 
appraised by the person as taxing or exceeding his or her resources and endangering his or her 
well-being” (Lazarus & Folkman, 1984, p. 19). This study focused on the degree to which the 
relation between a person and a diagnosis of cancer and its treatment are appraised as taxing, 




is a threat to well-being because the survival rate is so low. Sources of stress for LC and HNC 
patients include: physical side effects of treatment, negative implications for daily living, 
financial burden, and role changes.  
Previous studies have found evidence of the link between psychological symptoms 
experienced with a cancer diagnosis/treatment and trauma symptoms (Andrykowsk & Kangas, 
2010). In addition to diagnosis, the disgust response to treatment side effects is also a stressor 
(Powell, Azlan, Simpson, & Overton, 2016). These events are all considered stressors that 
present once someone is diagnosed with and begins treatment for LC and/or HNC cancer. 
 In addition to physical side effects of treatment, stress also stems from LC and HNC 
impacting many domains of daily living (Hansen & Sawatzky, 2008; Devins et al., 2013). Basic 
tasks of daily living are often a stress for LC and HNC patients. Patients report difficulty with 
breathing, talking, sleeping, eating and drinking, and sexual intimacy (Lou, Chen, He et al., 
2017; Fodeh, Lazenby, Bai, Ercolano, Murphy, & McCorkle, 2013; Lindau, Surawska, Paice, & 
Baron, 2011).  
 LC and HNC patients face financial stressors associated with the cost of treatment and 
the need to leave work (Shart, Carsin, & Timmons, 2013).  Cost of LC and HNC treatment is 
steep for both patients and insurance companies (Cipriano et al., 2011). The average cost of the 
most common type of LC is approximately $2,000 in patient out-of-pocket cost. Insurance 
companies typically pay $67,000. Medically underserved patients, by definition, have minimal 
funds and insurance to cover their costs. In addition, cancer patients are often unable to work for 
periods of time during and after treatment (ACS, 2017). Patients often spend time way from 




patients, especially those who are underserved. Both the cost of treatment and the loss of income 
influence financial stress of LC and HNC diagnosis. 
 A third area of stress comes from inability to maintain previous roles (Downe-Wamboldt, 
Butler & Couler, 2006; Ledeboer, Velden, Boer, Feenstra, & Pruyn, 2005).  As discussed, a 
patient might need to leave work and find that changing taxing or exceeding their resources. An 
individuals’ sense of self is often negatively impacted. Because surgical treatments of the head, 
neck, and lungs are common within this population, sense of self is often diminished due to 
major changes in appearance or ability to speak the way they had before cancer (Carper, 
Fleishman & McGuire, 2004). Many patients begin to rely more on their partners for daily care, 
which can be appraised as taxing or exceeding resources of either partner in a relationship. As 
parents, LC and HNC patients are sometimes unable to care for their children in the same way as 
they previously could (Schmidt, Damm, Prenzler, Golpon & Welte, 2016). LC and HNC 
diagnoses and treatment increase stress in interpersonal relationships (Kaptein, Kobayashi, 
Matsuda, Kubota, Nagai, & Momiyama et al, 2015). As discussed, some cancer patients who 
need to leave work. This can leave patients with a lost sense of meaning and purpose when they 
are unable to work. Clearly, intrapersonal sense of self and interpersonal relationships are 
impacted by LC and HNC. 
 Stressors of physical illness, changes in daily living, finances, and role changes 
contribute to a patients overall psychological state. One way to conceptualize the impact of stress 
is as a contributor to symptoms of anxiety and depression, referred to in this study as “emotional 
distress”. Previous research indicates that LC and HNC patients show symptoms of emotional 




Some researchers have explored how stressors are related to emotional distress (Kugaya et al 
2000). 
Emotional Distress 
Depression LC and HNC patients report an elevated level of depressive symptoms 
compared to the general public (Krebber et al. 2014). Symptoms of depression include: sad or 
depressed mood most days of the week, diminished interest and motivation in activities, 
significant change in appetite with either over- or under-eating, changes in sleep, fatigue, 
restlessness or psychomotor agitation, feelings of worthlessness, diminished ability to think or 
concentrate. Sometimes people experiencing depression have thoughts of death or suicide. While 
depression is a disorder recognized by the American Psychiatric Association with a prevalence 
rate in the US population of seven percent each year, there are many people who may experience 
depressive symptoms without receiving a diagnosis (American Psychiatric Association, 2013). 
For individuals experiencing depressive symptoms, there is a range of impairment to functioning 
in physical ability, social connectedness and other social roles (American Psychiatric 
Association, 2013). 
 Depression symptoms can be present at any stage of cancer and at various time points 
during treatment (Krebber et al., 2014). A meta-analysis by Krebber et al. (2014), estimated that 
the prevalence of depression associated with LC is 3 percent. However, other studies estimate 
that rates of depression for cancer patients are much higher. Other data approximate that 50 
percent of HNC patients, and 11-44 percent of LC patients, report depressive symptoms (Massie, 
2004). There is evidence that there prevalence rates differ due to racial/ethnic differences, with 




(Alcalá 2014). Factors that have been identified as important to increased risk of depression in 
HNC patients are malnutrition and lack of social support (Frampton, 2001).  
Previous research indicates differences in the experience of depression based on 
characteristics like age, gender, and stage of cancer. Carver and Connor-Smith (2010) found that 
older adults have an easier time matching coping strategies to bad news, like a cancer diagnosis, 
because they have lived experience with more negative events than younger people. Adams, 
Winger and Mosher (2015) suggest this might mean younger adults experience more distress 
than older adults when given a cancer diagnosis. When assessing cancer survivorship, younger 
adults tend to report poorer well-being, more depressive symptoms and anxious symptoms after 
their treatment ends (Costanzo, Tyff & Singer, 2009). Costanzo, Tyff and Singer propose that a 
developmental theory explains this difference in distress by years of age. According to 
Neugarten & Hagestad, 1976, a developmental explanation is that a cancer diagnosis is a “off-
time” life event for younger people where in such a diagnosis is not inside a typical 
developmental trajectory and is distressing and possibly traumatic.   
 Anxiety Anxiety is described as anticipating threat when no actual threat is present 
(American Psychiatric Association [APA], 2013). Minimal sense of control is common for 
people experiencing anxiety. In preparation for a fear response, people with anxiety experience 
muscle tension and vigilance. When feelings of fear and avoidance of anxiety-provoking 
situations become severe, an anxiety disorder may be diagnosed (APA, 2013). However, many 
cancer patients experience anxiety symptoms without meeting criteria for a diagnosis (ACS, 
2017). Whether an individual meets criteria for a diagnosis or not, experiencing symptoms of 
anxiety can make it challenging to fulfill social and occupational roles (American Psychiatric 




 These studies shed light on the impact that LC and HNC diagnoses have on patients’ 
emotional distress, including how they might contribute to depression and anxiety symptoms in 
this patient population. Because emotional distress is treatable, it is worthwhile to assess for 
depressive and anxious symptoms early in the patient’s treatment trajectory (American 
Psychiatric Association, 2013). Thus, screening for symptomology at the time of diagnosis can 
help health care providers understand the trajectory of emotional distress for underserved LC and 
HNC patients. Once the timeline of emotional distress is understood, interventions that target 
indicators of emotional distress will be beneficial to patient’s mental health. 
Transactional Model of Stress and Coping 
 Health psychology researchers are interested in the ways that stress and emotional 
distress are related. Because emotional distress symptoms vary in intensity for LC and HNC 
patients, it is insufficient to conclude that stress directly causes emotional distress. The intent of 
this study was to examine how the two experiences, stress and emotional distress, are related. A 
well tested theoretical model, the Transactional Model of Stress and Coping (TMSC), is 
proposed as the best way to understand the relation between stress and emotional distress. 
 Richard Lazarus and Susan Folkman proposed the TMSC in 1984. The model focuses on 
the relation between a stressful circumstance, in this study a cancer diagnosis, and the experience 
an individual has of the stressful circumstance. TMSC posits that there is a process of cognitive 
appraisal mediating the relation between a potentially stressful environmental situation and the 
experience of stress. Lazarus and Folkman define psychological stress as “a relationship between 
the person and the environment that is appraised by the person as taxing or exceeding his or her 




  A key component of this definition of stress is cognitive appraisal. Cognitive appraisal is 
defined as one’s beliefs about a stressful situation. Cognitive appraisal has a primary and a 
secondary component. Primary appraisal involves the person assessing if there is a presence of 
stress. When stress is perceived to be present, secondary appraisal also occurs. In secondary 
appraisal, the person is in the process of deciding how to handle the stress (Lazarus and 
Folkman, 1984). This process of deciding how to handle stress is called coping. 
 Coping Coping is the term used for the process of deciding how to manage stress. 
Coping is defined as “constantly changing cognitive and behavioral efforts to manage specific 
external and/or internal demands that are appraised as taxing or exceeding the resources of the 
person” (Lazarus and Folkman, 1984, p. 141). In the TMSC, coping is categorized as either 
emotion-focused or problem-focused. Emotion-focused coping approaches focus on 
manipulation of one’s internal experience of the stressor. On the other hand, when using 
problem-focused coping, people attempt to change or solve aspects of the environmental 
situation. The use of emotion-focused and problem-focused coping strategies can lead to 
adaptive of maladaptive outcomes in living (Lazarus and Folkman, 1984). 
 In TMSC, adaptive and maladaptive outcomes in the quality of life are assessed. 
Adaptive and maladaptive outcomes are evaluated in social relationships, morale, and somatic 
health. In this study, maladaptive outcomes are analogous to emotional distress. The focus in the 
TMSC is that perception of stress and use of coping strategies are always changing. The process 
of cognitive appraisal is dynamic and bidirectional (Lazarus and Folkman, 1984). By using the 
TMSC to organize the analysis of this study’s data, it was hypothesized that levels of emotional 




 Emotional Distress Over the Course of Treatment There is evidence that the TMSC is 
useful for understanding the experience of other cancer patients (Park & Folkman, 1997). 
Burgess and colleagues (2005) found emotional distress among 33 percent of breast cancer 
patients who reported experiencing depression and anxiety at the time of diagnosis. Three 
months after diagnosis, the prevalence of anxiety and depression decreased to 24 percent. After 
one year of treatment, only 15 percent of patients reported experiencing anxiety and depression 
(Burgess et al., 2005). Previous research has found that distress levels change over the course of 
treatment in LC studies (Cooley, Short, & Moriarty, 2003). 
Purpose of Current Study 
 The purpose of this study was to understand how stress, coping, and emotional distress 
are related. This study tested a predictive relation between the stress of LC and/or HNC 
diagnosis and emotional distress for medically underserved patients. Coping was tested as a 
variable moderating the effect of stress on emotional distress. Previous research using the TMSC 
has explored these relations and found support for coping as a moderator between stress and 
emotional distress. However, this study expands on previous research by examining these 
relations that have not been tested among a sample of medically underserved LC and HNC 
patients.  
1. Primary research question: What is the relation between stress of LC and/or HNC 
diagnosis and emotional distress for medically underserved patients?  
2. Secondary research question: Is the relation of stress and emotional distress 







1. Hypothesis 1: There will be a positive association between stress and emotional 
distress among medically underserved LC and HNC patients after diagnosis.   












 The current study was part of a larger ongoing randomized control trial (RCT) funded by 
the  Patient-Centered Outcomes Research Institute (PCORI) (Evelinn Borrayo, PI). The larger 
study is titled “A Stepped-Care Intervention to Reduce Disparities in Mental Health Services 
among Underserved Patients and Caregivers with Lung and Head and Neck Cancer.” The larger 
study focuses on adapting evidence-based Cognitive Behavioral Therapy (CBT) treatment to fit 
with the level of mental health symptoms patients and caregivers are experiencing (stepped-
care). The aim of the larger study is to compare this stepped-care approach to enhanced usual 
care. The project is multisite with standardized protocol between sites for training, recruiting 
participants, and administering measures. The current proposed study did not focus on the 
intervention, rather the relation of stress, coping, and distress at the baseline cross-section of all 
patients recruited into the study.  
Participants 
Participants in the study were medically underserved and have recently received a 
diagnosis of LC and/or HNC. Patients were recruited within 30 days of their first oncology 
appointment. They were recruited from four Colorado hospitals: Denver Health Hospital in 
Denver, Saint Mary’s Hospital and Reginal Medical Center in Grand Junction, Saint Joseph 
Hospital in Denver, and National Jewish Health in Denver. English and Spanish speaking 
patients were recruited. Per qualifying criteria, all patients were medically underserved. For this 
study, medically underserved is defined as meeting one or more of the following criteria: living 
below 400 percent of the 2016 Federal Poverty Level (FPL), uninsured or underinsured with 




200 percent of the 2016 FPL and spend more than 10 percent of annual income on out-of-pocket 
medical expenses. 
Sample size calculation A gap in the literature exists such that there are no studies that 
provide information about the effects of stress and coping on experienced distress for this 
specific population. Previous studies estimate the percentage of cancer patients that experience 
depression and anxiety to be between 6-21 percent (Walker, 2014 et al). Information about the 
effect of stress and coping on emotional distress was estimated based on previous studies. One 
study of cancer survivors measured a .27 R2 effect of stress coping-style on the outcome of 
emotional health behaviors (Parelkar, Thompson, Kaw, Miner, & Stein, 2013). It is important to 
note that this sample studied people who had survived cancer and were currently in remission. 
Because there is limited literature that reports effect size estimates for this population, it is 
difficult to estimate the sample size needed to find an effect of stress and coping on emotional 
distress. Thus, to calculate the sample and power for the current study, the only similar study 
(Parelkar et al, 2013) R2 effect size of .27 was utilized. Using the f2=.37 effect size, power of .95, 
6 predictors (age, gender, stage of cancer, stress, coping, stress X coping), Gpower software 
(Faul, Erdfelder, Buchner & Lang, 2009) estimated that 64 participants would be needed for a 
fixed multiple regression analysis, R2 derivation from 0.  
A post-hoc power analysis was computed using G*Power. Power analysis was used to 
measure the probability of rejecting the null hypothesis that there is no effect of stress, coping, 
and their interaction on depression and anxiety. For depression, an F-test, R2 derivation from 0 
was computed using f2=1.17, alpha=.05, total sample size 188, number of predictors=6. The 
power calculated was 1.00 indicating that there was enough power to reject the null hypothesis. 




size=188, total predictors=6. Results indicated power of 1.00 indicating the study had enough 
power to reject the null hypothesis. 
Measures 
 Demographic information. Demographic variable of interest were collected about age, 
race/ethnicity, sex, and stage. Age, stage 0, stage 1, stage 2, stage 3, stage 4, and gender were 
controlled for due to impact of these variables that were established in previous studies. 
 Perceived Stress Scale The Perceived Stress Scale (PSS) was used to measure to what 
extent events in the last month were appraised as stressful. While there are multiple versions of 
the PSS, the version in the study had 10 items with 5-items Likert type scale. Principle 
components analysis (PCA) of the PSS-10 had a resulting .42 first factor loading. In the PCA 
two factors emerged, one of positively worded questions and a second factor for negatively 
worded questions. The total explained variance was 48.9 percent when factors were combined. 
This scale has been used with cancer patients and its internal consistency reliability ranges 
between .80 and .89. This scale’s predictive validity is interpreted to last 4-8 weeks because it 
measures current daily stress (Cohen, Kamarck, & Mermelstein, 1983; Cohen & Williamson, 
1988). The review also found evidence that White people had lower scores on the PSS than 
Black, Hispanic and other minority individuals (Cohen, Kamarck, & Mermelstein, 1983). For 
this study, internal consistency (Chronbach’s alpha) was calculated for PSS (α=.86). 
Coping Self-Efficacy Scale The Coping Self-Efficacy Scale (CSES) was used to 
measure how much confidence a person has in their ability to cope when things are not going 
well. An exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were used to 
measure factor structure of the scale. Results indicate there are three separate factors: problem 




α=.80). The first two factors coincide with the TMSC problem-focused and emotion-focused 
coping. Internal consistency and test-retest validity were strong for all factors. The results 
indicate that the scale has predictive properties. When scores on this coping scale increase over 
time, scores on measures of psychological distress are lower (Chesney et al., 2006). For this 
study, internal consistency (Chronbach’s alpha) was calculated for CSES (α=.96). 
 The CSES has been adapted for this low literacy population to include three options in 
the response scale instead of the original 1-10 scale. Because this sample qualifies as medically 
underserved, there are mostly of low socioeconomic status (SES), which correlates with low 
literacy (Buckingham, Wheldall, & Beaman-Wheldall, 2013). Choices for participants include 
“Certainly cannot do”, “Maybe can do”, and “Certainly Can Do”. Although cutting down the 
number of response items reduces variability, the research team decided it would be more 
appropriate for this sample.  
Patient-Reported Outcomes Measurement Information System The Patient-Reported 
Outcomes Measurement Information System (PROMIS) was developed to measure the impact of 
chronic illness on health related quality of life. The measures correlate with specific DSM-V 
diagnostic criteria.  
 Depression The PROMIS Cancer Depression 32 item scale has a bank of items that can 
differentiate from other psychological illness and leaves out somatic symptoms that could be due 
to physical illness. (National Institute of Health, 2007; Choi, Schalet, Cook & Cella, 2014) The 
PROMIS Depression measure is a T-score metric with a mean of 50 and standard deviation of 10 
(Pilkonis, Yu, Dodds, Johnston, Maihoefer & Lawrence, 2014). Previous measures of reliability 
for this scale give a Cronbach’s alpha of .92 (Pilkonis, Yu, Dodds, Johnston, Maihoefer & 




and the Center for Epidemiological Studies Depression scale (CESD) were statistically 
significant (.72-.84) with a sample of about 194 depressed outpatients ranging from ages 18-83 
across three time points (Pilkonis, Yu, Dodds, Johnston, Maihoefer & Lawrence, 2014) 
 Anxiety The PROMIS Cancer Anxiety scale focuses on fear, anxious misery, 
hyperarousal, and somatic symptoms and has been established as a common metric (Shalet, 
Cook, Choi & Cella, 2014). Schalet et al (2016) found the PROMIS Anxiety cancer standard 
response mean to be between .35 and .72. PROMIS items range in alpha levels from .86 to .97 
(Cella et al., 2014; Cella et al., 2008). 
 Assessment of Chronbach’s alpha for PROMIS-Depression was .97 and PROMIS-
Anxiety was .97. These scores were calculated using the raw PROMIS data. However, calculated 
T-scores from REDCap database were used in the data analysis. 
Procedures   
Institutional Review Board (IRB) approval was obtained through the Colorado Mult-
Institutional Review Board through the University of Colorado Denver for the aforementioned 
PCORI-funded study. To identify eligible participants there was a monthly audit of medical 
records at each hospital site to find newly diagnosed LC and HNC patients. In addition, 
physician and research coordinator attendance at cancer tumor boards, and daily reviews of LC 
and HNC patients who visit oncology clinics, ear-nose-and-throat (ENT) clinics, and radiation 
oncology units at each hospital will help to identify possible patient participants. Site Research 
Coordinators (SRC) discussed the study with the patients at the time of their first oncological 
appointment. As patients expressed interest, SRCs followed HIPPA compliant procedures to 




agreement and consent were administered electronically and participants were offered a hard 
copy for their own records.  
After being consented, patient participants were given the baseline survey, either via 
email or paper copy. If a patient was unable to fill out a survey on their own, one acceptable 
mode of administration was paper format with a SRC in person. Based on the patient’s primary 
language, measures were administered either in Spanish or English. The baseline survey includes 
a demographics questionnaire, PSS, CSES, PROMIS-Ca Depression and PROMIS-Ca Anxiety. 
When patients return baseline surveys they received a $25 gift certificate in the mail. All 
responses from the baseline measure were entered into a secure REDCap database. This author 
was involved in construction of the demographics and baseline survey, called participants to 
remind them to complete surveys after being consented, and worked on general administrative 
tasks for the PCORI project and the collection of data for this study. For this study, data will be 
used from all participants in the project who qualify as underserved because this study focuses 







Missing Data and Tests of Assumptions 
Data were analyzed for exclusion criteria and missing variables. Data from participants 
who met exclusion criteria (e.g. were incarcerated, had serious mental health diagnoses, were 
pregnant) was deleted. Missing data, due to questionnaire skips, was then assessed to determine 
whether or not it was missing at random. Missing not at random is problematic because it may 
indicate that something about the item influenced missing answers. Sometimes there are 
characteristics about an item the respondents find to be offensive or too revealing to answer. 
Items like this sometimes are left missing systematically (Little & Rubin, 2019). Missing data 
from control variables (age and sex) were assessed for the assumption of Missing Completely at 
Random (MCAR) and determined to be missing completely at random so no further assessment 
was needed (χ2=220, DF=2, p=.90). The items of the Perceived Stress Scale (PSS) were assessed 
with MCAR and it provided evidence that items were missing at random based on observed 
variables (χ2=49.21, DF=53, p=.623). The items of the Coping Self-Efficacy Scale (CSES) were 
assessed for data missing not at random which was significant (χ2=309.69, DF=223, p=.000). 
Further analysis of the data indicated that one questions was missed 5 times (2.3% of the time). 
The question was “Pray or Meditate” to which respondents were expected to answer if they 
could use to cope. Because some people may not have felt comfortable answering a questions 
related to religion/spirituality, these 5 missing values were replaced by the mean. This choice 
was made so as not to get rid of a potentially important item in the scale and to delete those who 
did not want to disclose information about spiritual or religious beliefs from the study. Analyses 




negligible. PSS and CSES used sum totals to calculate scores so no data could be missing from 
these scales. As such, all remaining participants who had missing data were deleted listwise. 188 
participants remained for further analysis out of 213. 
 The data was then assessed for linear regression test assumptions including linearity, 
homoscedasticity, normality and independence. Linearity was tested by regressing the 
standardized residuals of the outcome variables (depression and anxiety) against the standardized 
residuals of the predictors variables (perceived stress and coping). Scatter plots showed that all 
relations appeared linear such that each of the following was linear: the relation of perceived 
stress to depression; perceived stress and coping to depression; perceived stress to anxiety; and 
perceived stress and coping to anxiety. These plots demonstrated a linear relation between 
variables so a linear regression analysis was deemed to be appropriate. 
Next, assumptions of homoscedasticity were tested to assess for equality of variance of 
the data across all levels of the predictors. Homoscedasticity was analyzed using scatter plots to 
visually represent the degree of variance in responses. Each plot (perceived stress to depression; 
perceived stress and coping to depression; perceived stress to anxiety; and perceived stress and 
coping to anxiety) reveled heteroscedasticity visually. Further testing was done using Modified 
Breusch-Pagan tests to test the null hypothesis of homoscedasticity. Chi-squares were significant 
for each model which indicated the assumption of homoscedasticity was not upheld, which is not 
acceptable because it indicates that the data was not equally variable across all levels of the 
predictor (χ2=26.98, p=.00;  χ2=36.04, p=.00; χ2=11.77, p=.00; χ2=9.90, p=.00). A 
heteroscedasticity-corrected matrix was then used because the Chi-square tests were significant. 




of heteroscedasticity did not impact the model to a degree that the analysis was impacted. As 
such, no adjustments were made to the data. 
 Next, outcome data was assessed for normality of the distribution (e.g. skew and 
kurtosis). An acceptable range for each is (-2,2) (Kline, 2005). For PROMIS-Depression skew 
and kurtosis were determined to be within acceptable limits (Skew=1.297, SE=.177; Kurtosis= 
.843, SE=.353). For PROMIS-Anxiety skew and kurtosis were also determined to be within 
normal limits (Skew=.878, SE=.177, Kurtosis= -.101, SE= .353). 
 Then the data was assessed for multicollinearity which tests the extent to which scales are 
correlated with other scales. It is important the each predictor in the model has the potential to be 
uniquely related to the outcome. If two predictors are very highly correlated, then the collinearity 
impacts interpretation of the regression coefficients. One widely accepted limit of 
multicollinearity, .80, was used for this analysis (Thompson, Kim, Aloe, Becker, 2017). Tests 
determined that scales correlated between -.68 to .79 and as such were determined to not have 
problems of multicollinearity (See Table 2). The correlation that approached .80 was the 
correlation between anxiety and depression which are theoretically similar in that they are 
emotional distress. Assumptions of independence were upheld. 
Descriptive Statistics 
Descriptive statistics including frequencies, means, standard deviations, reliabilities 
correlations were conducted. Frequencies for variables of sex, stage, race, age, and ethnicity are 
listed in Table 1.  Correlations indicate that all variables were significantly related at a .001 level 





The first hypothesis outlined in this study was that there would be a positive association 
between stress and emotional distress among medically underserved LC and HNC patients after 
diagnosis. A linear regression was fit to the data to test this hypothesis. The analysis first 
controlled for variables of sex, age, and stage of cancer based on previous research. Then, 
perceived stress was used to predict outcomes in anxiety and depression. Perceived stress was 
centered at the mean in order to define a meaningful intercept. Results of linear hierarchal 
regression modeling indicated that, when controlling for sex, age, and stage of cancer, perceived 
stress has a significant positive association with depression (b=.52, p<.001) and anxiety (b=.62, 
p<.001) (see Table 3 & Table 4). The model for the relationship between of perceived stress and 
depression indicated that 6 percent of the variance was accounted for by control variables. The 
R2 change was 41 percent when perceived stress was added to the model. The model for the 
relationship between of stress and anxiety indicated that 9 percent of the variance in scores was 
explained by the control variable. The R2 change was 43 percent when stress was added to the 
model for anxiety.  
The second hypothesis was that coping would moderate the relationship between stress 
and emotional distress. The proposed method to test this hypothesis was to use linear regression 
analysis. The analysis first controlled for variables of sex, age, and stage of cancer. Then, 
perceived stress, coping, and an interaction term of perceived stress and coping, were used to 
predict outcomes in anxiety and depression. Coping and stress were centered at the mean prior to 
analysis to create a meaningful intercept for each variable and so that each simple slope would 
represent the effect when the other variable was at the mean. Results of linear hierarchal 




significant moderating effect on the influence of stress on depression (b=-.02, p<.001) and 
anxiety (b=-.01, p<.000) (see Table 5 & Table 6). The model for the impact of coping 
moderating the impact of perceived stress on depression indicated that 6 percent of the variance 
was accounted for by control variables. The R2 change was 48 percent when coping, perceived 
stress and their interaction were added to explain depression. The model for the impact of stress 
on anxiety indicated that 9 percent of the variance in scores was explained by the control 
variables. The R2 change was 47 percent when coping, perceived stress and their interaction were 
added to explain anxiety.  
Additional analysis was done to probe the significant interaction. Hayes PROCESS 
Macro was used with SPSS to assess for the impact of coping on the relation of stress and 
distress by probing at three levels of coping (Hayes, 2017). The results of PROCESS Model 1 
indicated that the effect of stress on depression was significant when coping was 1 standard 
deviation below the mean (b=.58), at the mean (b=.41) and 1 standard deviation above the mean 
(b=.28) and on anxiety when was coping was 1 standard deviation below the mean (b=.63), at 
the mean (b=.51) and 1 standard deviation above the mean (b=.40), so coping was consistently 
identified as a significant moderator for both outcomes. However, the effect of stress on anxiety 
and depression was mitigated as coping increased and are represented as simple slopes in the 
figures (See Figure 1 and 2). There were no statistically significant transition points within the 
observed range of the moderator found using the Johnson-Neyman method. That is, stress 







The intent of this study was to examine the relation of stress, coping, and emotional 
distress (symptoms of anxiety and depression) of medically underserved LC and HNC patients. 
Specifically, the intent of this study was to use the theoretical Transactional Model of Stress and 
Coping to explain the relations of these variables. The TMSC posits that stress is positively 
related to emotional distress. The model also posits that the relation of stress to emotional 
distress is moderated by coping. Therefore, the first aim of this study was to assess for the 
relation of stress to emotional distress. Results indicated significant and positive relation of 
levels of perceived stress and emotional distress. A second aim of this study was to assess for a 
significant moderating effect of coping on the relation of stress to emotional distress. Results 
suggest coping was a significant moderator. 
Perceived Stress and Emotional Distress 
 Previous research indicates that an individual’s level of stress is positively related to their 
experience of emotional distress. Emotional distress for this study was measured using 
symptoms of depression and anxiety. The first hypothesis of this study was supported because 
levels of stress were found to positively relate to emotional distress. A large portion of the 
variance in depression and anxiety scores was attributed to amount of perceived stress. These 
results lend support for the use of TMSC for the specific population. While research exists for 
the relation of stress on emotional distress for LC and HNC cancer patients, these results specify 
values for the amount that stress impacts depression and anxiety symptoms for medically 




 In the context of cancer research, many researchers have been interested in the positive 
relation of a stressful cancer diagnosis and treatment to experience of emotional distress (Kupst, 
Butt, Stoney, Griffith, Salsman, Folkman, & Cella, 2015; Swartzman, Booth, Munro, & Sani, 
2017). This relation of stress to distress seems to be well established. In this study, the relation 
was deemed to be linear across cases. Some studies of medically underserved patients have 
attempted to measure main sources of impact on receiving a stressful diagnosis including parsing 
out how much perceived stress can be attributed to low SES, race/ethnicity, and gender (Islami, 
Kahn, Bickell, Schymura, & Boffetta, 2013). Yin, Morris, Allen, Cress, Bates and Liu (2010) 
analyzed data from five major cancer sites to assess for differences in cancer incidence among 
varying racial/ethnic and SES. Their findings indicate that for most groups, incidents of LC 
increased with decreased SES, however this relation was opposite for Hispanic men and women. 
Each of these factors seem to have their own impact on the perceived stress and emotional 
distress which underserved cancer patients face. This study specified the relation of perceived 
stress of diagnosis and treatment to emotional distress for a majority White, non-Hispanic 
medically underserved population of LC and HNC patients in Colorado. 
Perceived Stress, Coping, and Emotional Distress 
 As discussed, the results of this study demonstrated a positive relation of perceived stress 
to emotional distress. These results illuminate the difficult reality of a stressful LC or HNC 
diagnosis. However, the TMSC, which was tested with these analyses, also theorizes that 
adaptive coping can help to decrease the impact that stress has on emotional distress. Coping, for 
this study, was defined as the way a person manages a stress (Lazarus & Folkman, 1984).  
 Results of the moderating effect of coping were significant. This indicates that an 




adaptive coping helped to decrease the impact of perceived stress on the presence of depression 
and anxiety symptoms. Coping was observed to decrease the impact of stress at high, medium, 
and low levels of coping. This is informative and encouraging because regardless of the level of 
coping a participant had, their coping did help to buffer the impact of stress on emotional 
distress. It is important to note that for participants with higher coping, the impact of perceived 
stress on emotional distress was smaller than for participants with lower levels of coping. These 
results support the use of the TMSC with medically underserved LC and HNC patients. 
 In reviewing the literature, it was clear that there was a gap in the understanding of how 
much coping moderated the relation of perceived stress to resultant emotional distress for this 
population. Only one estimate of this effect was found and it was not specific to underserved LC 
and HNC patients (Parelkar et al, 2013). Now, three measures of this impact have been created 
for varying levels of the moderator. 
 The broader research area of moderators and mediators for distress in cancer research has 
been wide and varied to include many kinds of coping assessments and coping interventions 
(Moyer, Goldenberg, Hall, Knapp-Oliver, Sohl, Sarma & Schneider, 2012). For underserved 
cancer patients, this study serves as part of the growing literature to understand the impact of 
coping skills and resources available to learn how to cope for this population (Thompson, 
Shelton, Mitchell, Eaton, Valera, & Katz (2013). Carrion, Nedjat-Haiem, Macip-Billbe, and 
Black (2017) used qualitative methods to assess for coping strategies used by Latino cancer 
patients; the study included a majority of breast cancer and prostate cancer patients. Results 
indicated that Latinos used coping which included meaning-based coping, family support, and 
religion and spirituality. The CSES measured used in this study did include items related to each 




Implications for Research and Practice 
 Results of this study have promising implications for research and practice. This research 
adds to the field a snapshot of the perceived stress, coping, and emotional distress present at the 
time of diagnosis for medically underserved LC and HNC patients. Implication for this research 
include supporting an integrative theory, providing estimates of effects, providing a place of 
intervention of clinicians working with LC and HNC, and lends support for the larger PCORI 
study that this data was extracted from. 
 The first implication of this study is the support for the use of the TMSC as an 
appropriate model for medically underserved LC and HNC patients. The TMSC has been tested 
with varying populations of people with health concerns, including cancer patients (Sorato & 
Osório, 2015). However, after a review of the literature, it had not been tested specifically with 
medically underserved LC and HNC patients in the United States. Results of this analysis 
support future use of the TMSC with this population.  
 Another implication for this study is a measure of the impact that stress and coping have 
of emotional distress. This study used valid and reliable measures to estimate the impact that 
stress and coping having on symptoms of anxiety and depression for this specific population. 
This study used the PROMIS measures to evaluate depression and anxiety symptoms, which 
goes a step beyond other research that focused on the construct of quality of life which is often 
used as the outcome variable in cancer research (Rinaldis, Pakenham, & Lynch (2012). Previous 
studies typically included patients with various cancer diagnoses, did not include the effect size 
of the interaction of stress and coping, and were not specifically observing medically 




variables and population can have estimated of the effect size of stress and coping on emotional 
distress for this population. 
 Clinically, the results of this study can provide a helpful tool to assess for risk of 
emotional distress. If a clinician can assess for stress and coping of a medically underserved LC 
or HNC patient, they can make informed assessment of the patient’s emotional distress. For 
example, for clients with high levels of stress and low coping, clinicians can been particularly 
attuned to the increased chances for high levels of emotional distress. Additionally, clinicians 
and patients alike can use this information as a source of hope for relief from emotional distress. 
Hope has shown to be an impactful construct in impacting coping with emotional distress for 
cancer patients (Griffith, 2014). Because results of this study indicate that higher coping lessens 
the impact of stress on emotional distress, learning how to cope effectively is a worthwhile 
endeavor. Research does support that coping can be learned (Brothers, Yang, Strunk, & Andersen, 
2011). The Brothers et al. article described that through CBT techniques such as assessing 
automatic thoughts, behavior activation, and adaptation of core beliefs about self, others, and the 
world, decreased symptoms of depression with cancer patients. 
 Lastly, since research indicates that coping can be taught, and because the results in this 
study support coping as a moderator, this study lends support for the larger PCORI study. The 
larger PCORI study from which this data was extracted aims to measure the changes in 
emotional distress over time when a CBT intervention is used to help increase coping skills. 
Results from the present study provide support for the continued analysis of the relations of 




Limitations and Future Directions 
One limitation of this study was the cross-sectional nature of the data. Observing 
participants at only one time-point limits the ability to gather information about the participants 
and forces the study design to rely heavily on theory for making conclusions about causality and 
directionality of the variables. For instance, this study relied heavily on the TMSC to determine 
perceived stress as the predictor, coping as the moderator, and emotional distress as the 
dependent variable. Relying on the theory and only having observed data at one time point may 
limit the ability to understand how these variables impact each other overtime. 
Another limitation of this study was having some missing data. While missing data is 
normal with human participants and was assessed appropriately for missing not at random, there 
may have been some participant information lost because of missing data. Lastly, this sample 
was largely comprised of data from White participants. According to the American Cancer 
Society, Black American and US living Hispanic/Latino people are more likely to be medically 
underserved than Non-Hispanic White people (ACS 2019). While the sample is specific in many 
was including only those LC and HNC patients who are medically underserved, the ability to 
generalize these finding may be limited by factors of race/ethnicity that were not fully 
represented in the data. Since previous research does indicate that race/ethnicity can have an 
impact of stress of diagnosis above and beyond socioeconomic status, this is a limitation. 
Future directions for data related to stress, coping, and emotional distress of medically 
underserved LC and HNC are promising. As more longitudinal data is analyzed, these variables 
can be observed overtime. Observing them over time will lead to continued understanding of the 
way stress, coping, and emotional distress impact each other. The TMSC is a reciprocal model 




& Folkman, 1984). As discussed above, research indicates coping can be learned. If coping can 
be learned, then emotional distress may be observed to decrease if measured longitudinally.  
Longitudinal data analysis, including both quantitative and qualitative measures, for this 
population will also aid in creating time appropriate interventions. Research indicates that levels 
of stress change over the course of cancer diagnosis, treatment, and remission (Cooley, Short & 
Moriarty, 2003). Researchers can utilize continued measures of stress, coping, and emotional 
distress to create appropriate interventions at each stage of illness as well as at varying levels of 










Study Demographic information, n=188 
  n % 
Sex   
   Male 113 60.1 
   Feale 75 39.9 
Age in years   
   75 and older 33 17.55 
   65-74  73 38.83 
   55-64 56 29.79 
   45-54 15 7.98 
   35-44 7 3.72 
   34 and below 4 2.13 
Ethnicity   
   Not Hispanic 150 79.8 
   Hispanic 37 19.7 
Race   
   White 161 85.6 
   Black 10 5.3 
   Asian 1 .5 
   American Indian/Native Alaskan 1 .5 
   Hawaiian 0 0 
   Other race 7 3.7 
Stage   
   0 59 31.4 
   1 25 13.3 
   2 41 21.8 
   3 45 23.9 












Variable   1    2      3                   4                     
1. Perceived Stress   
   
    
2. Coping -.52*   
 
3. Depression  
 























12.79             14.61                  
(5.64)            (6.53)            
Cronbach’s α .86 .96 .97                  .97                              





Hierarchical regression prediction of depression 
Variable B SE (B) t p LLCI ULCI 
Step 1       
Age -.09 .04 -2.54 .01* -.16 -.02 
Sex 1.17 .83 1.40 .16 -.48 2.82 
Stage       
  1 -.29 1.33 -.22 .83 -2.91 2.34 
  2 1.18 1.13 1.04 .30 -1.06 3.41 
  3 .70 1.10 .63 .53 -1.48 2.87 
  4 -.73 1.50 -.48 .63 -3.69 2.24 
       
Step 2       
Age -.02 .03 -.88 .38 -.08 .03 
Sex .38 .63 .59 .55 -.87 1.62 
Stage       
  1 .14 1.00 .13 .89 -1.84 2.11 
  2 .14 .86 .17 .87 -1.55 1.84 
  3 -.92 .84 -1.09 .28 -2.58 .75 
  4 -1.22 1.13 -1.08 .28 -3.45 1.01 
PSS .52 .04 11.78 .00** .44 .61 
Note: (N = 188). PSS = Perceived Stress Scale. R2 = .06 for control variables; R2 change = .41 
when predictors are included. Total R2 = .47. Note: Reference group for sex was males and 





Table 4  
Hierarchical regression prediction of anxiety  
Variable B SE (B) t p LLCI ULCI 
Step 1       
Age -.14 .04 -3.38 .00** -.22 -.06 
Sex .97 .95 1.02 .31 -.90 2.84 
Stage       
  1 .14 1.51 .09 .93 -2.85 3.12 
  2 1.87 1.29 1.45 .15 -.68 4.41 
  3 2.27 1.25 1.81 .07 -.20 4.75 
  4 -.43 1.71 -.25 .80 -3.80 2.93 
       
Step 2       
Age -.06 .03 -1.94 .05 -.12 .00 
Sex .03 .70 .04 .97 -1.34 1.40 
  1 .64 1.10 .58 .57 -1.54 2.81 
  2 .65 .94 .69 .49 -1.22 2.51 
  3 .37 .93 .39 .69 -1.46 2.19 
  4 -1.02 1.24 -.82 .41 -3.47 1.44 
PSS .62 .05 12.67 .00** .52 .72 
Note: (N = 188). PSS = Perceived Stress Scale. R2 = .094 for control variables; R2 change = .427 
when predictors are included. Total R2 = .521. Note: Reference group for sex was males and 






Hierarchical regression prediction of depression with coping as moderator  
Variable B SE (B) t p LLCI ULCI 
Step 1       
Age -.09 .04 -2.54 .01* -.16 -.02 
Sex 1.17 .83 1.40 .16 -.48 2.82 
Stage       
  1 -.29 1.33 -.22 .83 -2.91 2.34 
  2 1.18 1.13 1.03 .30 -1.06 3.41 
  3 .70 1.10 .63 .53 -1.48 2.87 
  4 -.73 1.50 -.48 .63 -3.69 2.24 
       
Step 2       
Age -.03 .03 -1.21 .23 -.08 .02 
Sex .63 .59 1.07 .29 -.54 1.80 
Stage       
  1 -.02 .94 -.02 .98 -1.87 1.83 
  2 -.34 .81 -.41 .68 -1.94 1.27 
  3 -.65 .79 -.83 .41 -2.20 .90 
  4 -1.07 1.06 -1.02 .31 -3.16 1.01 
PSS .42 .05 8.53 .00** .32 .52 
CSES -.09 .03 -2.71 .01** -.16 -.03 
PSSxCSES -.02 .00 -3.51 .00** -.02 -.01 
Note: (N = 188). PSS = Perceived Stress Scale. CSES=Coping Self-Efficacy Scale. R2 = .06 for 
control variables; R2 change = .48 when predictors are included. Total R2 = .54. Note: Reference 






Hierarchical regression prediction of anxiety with coping as moderator  
Variable B SE (B) t p LLCI ULCI 
Step 1       
Age -.14 .04 -3.38 .00** -.22 -.06 
Sex .97 .95 1.02 .31 -.90 2.84 
Stage       
  1 .14 1.51 .09 .93 -2.85 3.12 
  2 1.87 1.29 1.45 .15 -.68 4.41 
  3 2.27 1.25 1.81 .07 -.20 4.75 
  4 -.43 1.71 -.25 .80 -3.80 2.93 
       
Step 2       
Age -.07 .03 -2.34 .02 -.12 -.01 
Sex .25 .67 .38 .71 -1.07 1.57 
Stage       
  1 .55 1.06 .52 .61 -1.54 2.64 
  2 .28 .92 .31 .76 -1.52 2.09 
  3 .59 .89 .67 .50 -1.16 2.34 
  4 -.92 1.19 -.77 .44 -3.27 1.42 
PSS .51 .06 9.25 .00** .40 .62 
CSES -.10 .04 -2.66 .01** -.18 -.03 
PSSxCSES -.01 .00 -2.38 .02** -.02 -.00 
Note: (N = 188). PSS = Perceived Stress Scale. CSES=Coping Self Efficacy Scale. R2 = .09 for 
control variables; R2 change = .47 when predictors are included. Total R2 = .57. Note: Reference 
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PERCEIVED STRESS SCALE 
 
The questions in this scale ask you about your feelings and thoughts during the last month. In 
each case, you will be asked to indicate by circling how often you felt or thought a certain way. 
 
Name ____________________________________________________________  
Date _________ 
Age ________ Gender (Circle): M F Other _____________________________________ 
0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often 
1. In the last month, how often have you been upset because of something that happened 
unexpectedly?.................................. 0 1 2 3 4 
2. In the last month, how often have you felt that you were unable to control the important things 
in your life? .................................................. 0 1 2 3 4 
3. In the last month, how often have you felt nervous and “stressed”? ............ 0 1 2 3 4 
4. In the last month, how often have you felt confident about your ability to handle your personal 
problems? ............................................................. 0 1 2 3 4 
5. In the last month, how often have you felt that things were going your 
way?.................................................................................. 0 1 2 3 4 
6. In the last month, how often have you found that you could not cope with all the things that 
you had to do? ......................................................... 0 1 2 3 4 
7. In the last month, how often have you been able to control irritations in your 
life?................................................................... 0 1 2 3 4 
8. In the last month, how often have you felt that you were on top of things?..... 0 1 2 3 4 
9. In the last month, how often have you been angered because of things that were outside of 
your control?................................... 0 1 2 3 4 
10. In the last month, how often have you felt difficulties were piling up so high that you could 






Coping Self Efficacy Scale 
 
When things aren't going well for you, or when you're having problems, how confident or certain 
are you that you can do the following: 
 
Cannot do 0 
Maybe can do 1 
Cannot do 2 
 
For each of the following items, write a number from 0 - 2, using the scale above. 
When things aren't going well for you, how confident are you that you can: 
 
1. Keep from getting down in the dumps.   
2. Talk positively to yourself.   
3. Sort out what can be changed, and what can not be changed.   
4. Get emotional support from friends and family.   
5. Find solutions to your most difficult problems.   
6. Break an upsetting problem down into smaller parts.   
7. Leave options open when things get stressful.   
8. Make a plan of action and follow it when confronted with a problem.   
9. Develop new hobbies or recreations.   
10. Take your mind off unpleasant thoughts.   
11. Look for something good in a negative situation.   
12. Keep from feeling sad.   
13. See things from the other person's point of view during a heated argument.   
14. Try other solutions to your problems if your first solutions don’t work.   
15. Stop yourself from being upset by unpleasant thoughts.   
16. Make new friends.   
17. Get friends to help you with the things you need.   
18. Do something positive for yourself when you are feeling discouraged.   
19. Make unpleasant thoughts go away.   
20. Think about one part of the problem at a time.   
21. Visualize a pleasant activity or place.   
22. Keep yourself from feeling lonely.   
23. Pray or meditate.   
24. Get emotional support from community organizations or resources.   
25. Stand your ground and fight for what you want.   








   PROMIS - Ca Item Bank v1.0 - Emotional Distress - Anxiety      
Emotional Distress-Anxiety  
  
Please respond to each item by marking one box per row.  
  
  In the past 7 days…  
   Never  Rarely  Sometimes  Often   Always  
EDANX27  
I felt something awful would happen ........    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDANX53  
I felt uneasy ...............................................    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDANX05  
I felt anxious ..............................................    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDANX12  
I felt upset ..................................................    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDANX55  
I had difficulty calming down ..................   
1  
   
2  
   
3  
   
4  
   
5  
                   
EDANX01  
I felt fearful ..............................................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX02  
I felt frightened .......................................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX33  
I felt terrified ...........................................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX08  
I was concerned about my mental  health 
......................................................   
  
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX47  
I felt indecisive ......................................   
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX18  
I had sudden feelings of panic ................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX26  
I felt fidgety ............................................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDANX07  
I felt like I needed help for my anxiety ....   
1  
   
2  
   
3  
   
4  
   
5  
              
24 June 2016  






Emotional Distress-Depression  
  
Please respond to each item by marking one box per row.  
  
  In the past 7 days…  
   Never  Rarely  Sometimes  Often  Always  
EDDEP06  
I felt helpless ..............................................    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDDEP19  
I felt that I wanted to give up on everything 
................................................   
  
1  
   
2  
   
3  
   
4  
   
5  
                   
EDDEP35  
I found that things in my life were 
overwhelming ............................................  
  
1  
   
2  
   
3  
   
4  
   
5  
                   
EDDEP05  




   
2  
   
3  
   
4  
   
5  
                   
EDDEP41  
I felt hopeless ............................................    
1  
   
2  
   
3  
   
4  
   
5  
                   
EDDEP28  
I felt lonely ................................................    
1   
  
2  
   
3  
   
4  
   
5  
                   
EDDEP09  
I felt that nothing could cheer me up ........    
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP31  
I felt discouraged about the future ...........    
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP46  
I felt pessimistic .........................................    
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP17  
I felt sad .....................................................    
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP29  
I felt depressed ...........................................    
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP36  
I felt unhappy ..........................................     
1  
   
2  
   
3  
   
4  
   
5  
                  
EDDEP54  
I felt emotionally exhausted ....................     
1  





   
4  
   
5  
              
  
